Search Results - "Sloot, Yvette J. E."

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Effect of PTEN inactivating germline mutations on innate immune cell function and thyroid cancer-induced macrophages in patients with PTEN hamartoma tumor syndrome by Sloot, Yvette J. E., Rabold, Katrin, Netea, Mihai G., Smit, Johannes W. A., Hoogerbrugge, Nicoline, Netea-Maier, Romana T.

    Published in Oncogene (01-05-2019)
    “…PTEN hamartoma tumor syndrome (PHTS) is caused by inactivating germline PTEN mutations with subsequent activation of Akt-mTOR signaling, leading to an…”
    Get full text
    Journal Article
  2. 2

    The Influence of Energy Depletion by Metformin or Hypocaloric Diet on Thyroid Iodine Uptake in Healthy Volunteers: a Randomized Trial by Sloot, Yvette J. E., Janssen, Marcel J. R., van Herwaarden, Antonius E., Peeters, Robin P., Netea-Maier, Romana T., Smit, Johannes W. A.

    Published in Scientific reports (01-04-2019)
    “…Sufficient thyroid iodine uptake is needed to ensure effective radioactive iodine (RAI) treatment, which is mediated by the sodium-iodide symporter (NIS)…”
    Get full text
    Journal Article
  3. 3

    Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry by Hugen, Niek, Sloot, Yvette J E, Netea-Maier, Romana T, van de Water, Carlijn, Smit, Jan W A, Nagtegaal, Iris D, van Engen-van Grunsven, Ilse C H

    “…Abstract Background Metastatic disease is the main cause of cancer-related mortality in thyroid carcinoma (TC) patients. Clinical studies have suggested…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Insights into the role of IL-32 in cancer by Sloot, Yvette J.E., Smit, Johannes W., Joosten, Leo A.B., Netea-Maier, Romana T.

    Published in Seminars in immunology (01-08-2018)
    “…•IL-32 has emerged as a new player with complex roles in cancer and cancer-related inflammation, which are isoform dependent.•IL-32 expression is increased in…”
    Get full text
    Journal Article
  6. 6